| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/10/2011 | CN102144970A Alprostadil lipid nanosphere injection and preparation method thereof |
| 08/10/2011 | CN102144963A Citicoline sodium glucose injecta and preparation process thereof |
| 08/10/2011 | CN101810814B Medicament for curing cerebral palsy, hyperkinetic syndrome and dementia and preparation method thereof |
| 08/10/2011 | CN101797307B Phenethyl alcohol glycoside-containing callicarpa kochiana extractive and preparation method thereof |
| 08/10/2011 | CN101780207B Traditional Chinese medicine for treating nervous headache |
| 08/10/2011 | CN101780159B Preparation method of traditional Chinese medicine for treating insomnia with deficiency of both heart-qi and gallbladder-qi |
| 08/10/2011 | CN101732590B Chinese medicinal preparation for treating migraine |
| 08/10/2011 | CN101708310B Chinese medicinal preparation for treating neurotica |
| 08/10/2011 | CN101700270B Traditional Chinese medicine composition used for neurasthenia and preparation method and quality control method thereof |
| 08/10/2011 | CN101607961B Eszopiclone crystal and composition thereof |
| 08/10/2011 | CN101601679B Application of nicotinamide mononucleotide |
| 08/10/2011 | CN101585799B Method for preparing unsymmetrical bis(indolyl)methane compound |
| 08/10/2011 | CN101372507B Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof |
| 08/10/2011 | CN101361831B New use of geniposide in preparating drug of vascular dementia treatment |
| 08/10/2011 | CN101351466B Heterocyclic Janus kinase 3 inhibitors |
| 08/10/2011 | CN101287738B Imidazo benzodiazepine derivatives |
| 08/10/2011 | CN101185644B Use of agomelatine in obtaining medicaments intended for the treatment of periventricular leukomalacia |
| 08/10/2011 | CN101134069B Capsule for treating hieronosus |
| 08/10/2011 | CN101084925B Technology for producing pilose antler mother solution |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994199 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994193 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/09/2011 | US7994182 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect |
| 08/09/2011 | US7994163 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| 08/09/2011 | US7994156 Carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/09/2011 | US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
| 08/09/2011 | US7993878 Antibodies to human IL-1β |
| 08/09/2011 | US7993676 Free-flowing, powdery composition containing alpha-liponic acid (derivates) |
| 08/09/2011 | US7993671 Blend of: (a) one or more polymers; and (b) a drug that is liquid ad room temperature; free of water and other low boiling liquids; pressure-sensitive transdermal drug delivery system |
| 08/09/2011 | CA2731346A1 Compounds for the treatment of lysosomal storage diseases |
| 08/09/2011 | CA2572208C 3-carbamoyl-2-pyridone derivative |
| 08/09/2011 | CA2540768C Pyrazolo and imidazo-pyrimidine derivatives |
| 08/09/2011 | CA2520027C 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2463938C Polymer conjugates of opioid antagonists |
| 08/09/2011 | CA2451151C Carbamates of 2-heterocyclic-1,2-ethanediols |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2441534C Benzoaxathiepin derivatives and their use as medicines |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2428039C Serotonergic agents |
| 08/09/2011 | CA2422589C Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/04/2011 | WO2011094579A2 Mushroom compositions and methods for making and using |
| 08/04/2011 | WO2011094545A2 Compositions and methods for enhancing proteasome activity |
| 08/04/2011 | WO2011094431A1 Sustained-release nsaid/hmg coa reductase inhibitor compositions |
| 08/04/2011 | WO2011094283A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094273A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011093522A1 A cycloalkane derivative |
| 08/04/2011 | WO2011093512A1 Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent |
| 08/04/2011 | WO2011093352A1 Thiazole derivative |
| 08/04/2011 | WO2011092290A1 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| 08/04/2011 | WO2011092272A1 Gamma secretase modulaters |
| 08/04/2011 | WO2011092231A1 Cytokines for the treatment of addictions |
| 08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | WO2011092061A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/04/2011 | WO2011091973A1 5-nitro-8-hydroxyquinolines as inhibitors of cathepsin b |
| 08/04/2011 | WO2011091692A1 Uses of benzoate and its derivatives |
| 08/04/2011 | WO2011091461A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | WO2011049948A4 Neuroprotection and myelin repair using nestorone® |
| 08/04/2011 | WO2011038124A3 Systems and methods for treating depression, including the use of neurobehavioral tasks |
| 08/04/2011 | WO2011035314A3 Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states |
| 08/04/2011 | WO2011035030A3 Induction of neuronal differentiation in non-neuronal cells using a nucleic acid molecule |
| 08/04/2011 | WO2011031100A3 Aripiprazole-bentonite-aea hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 08/04/2011 | WO2010151852A3 Protease inhibitors, compositions and methods of use |
| 08/04/2011 | WO2003057161A3 BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
| 08/04/2011 | US20110190394 Carnitine granulate and methods for its production |
| 08/04/2011 | US20110190393 Novel and efficient method for the synthesis of an amino acid |
| 08/04/2011 | US20110190389 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| 08/04/2011 | US20110190361 Tricyclic compound and pharmaceutical use thereof |
| 08/04/2011 | US20110190360 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| 08/04/2011 | US20110190356 Compositions and Methods of Using (R)- Pramipexole |
| 08/04/2011 | US20110190354 Glycyrrhetinic acid derivative and use thereof |
| 08/04/2011 | US20110190351 Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same |
| 08/04/2011 | US20110190350 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 08/04/2011 | US20110190349 Tetrahydro-pyran derivatives |
| 08/04/2011 | US20110190348 Methods for treating cns disorders |
| 08/04/2011 | US20110190347 Methods for treating neuropathic pain |
| 08/04/2011 | US20110190345 Treatment of Psychosis with a 5HT2A Antagonist and a Metabotropic Glutamate Receptor Agonist or Potentiator |
| 08/04/2011 | US20110190344 Benzimidazole modulators of vr1 |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 08/04/2011 | US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190336 Azabenzimidazolones |
| 08/04/2011 | US20110190333 Dihydrotetrabenanzine for the treatment of anxiety |
| 08/04/2011 | US20110190332 Dopamine receptor ligands with enhanced duration of action |
| 08/04/2011 | US20110190331 Peripheral opioid receptor antagonists and uses thereof |
| 08/04/2011 | US20110190329 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190314 Pharmaceutical compositions and their methods of use |